Chatham Rock Phosphate Ltd (TSX-V: NZP; NZAX: CRP) has, subject to regulatory approval, retained Canadian company Mackie Research Capital Corporation as a market maker.

The arrangement will need to comply with guidelines and policies of the TSX Venture Exchange.

Chatham Rock’s chief executive Chris Castle said Mackie will trade Chatham shares on the TSX-V to maintain “a reasonable market and improving the liquidity of Chatham’s common shares.”

The agreement between Mackie will be on a month-by-month basis with Mackie to be paid $C3,500 per month. The engagement may be terminated by either party with written notice of 60 days.

Chatham Rock said Mackie is one of Canada's largest independent full service investment firms, and traces its roots back to 1921. It is privately owned by many of its 300 employees.